Objectives: High rates of carbapenem resistance in the human pathogen Acinetobacter baumannii threaten public health and need to be scrutinized.
Introduction
Acinetobacter spp., particularly Acinetobacter baumannii, are a leading cause of healthcare-associated infections, especially in ICUs. 1 A. baumannii infections are difficult to treat due to their extensive antimicrobial resistance. This species is able to rapidly acquire drug resistance genes by horizontal gene transfer through mobile genetic elements such as plasmids, 2 transposons 3 and resistance islands, such as A. baumannii resistance islands (AbaRs) with a Tn6019 backbone 4 and A. baumannii genomic resistance islands (AbGRIs). 5, 6 Carbapenems are the first-line choice for A. baumannii infection therapy, even though the resistance rate is increasing worldwide. The most widespread mechanism of resistance to carbapenems in A. baumannii is enzymatic degradation by OXA-type carbapenemhydrolysing class D b-lactamases (CHDLs), specifically OXA-23. 7 The bla OXA-23 gene has spread in Acinetobacter spp. and is associated with insertion sequences (ISs), primarily with ISAba1. 8 The IS copy upstream from the gene provides a strong promoter and, by bracketing the gene together with a copy downstream, often forms composite transposons Tn2006, 9 Tn2007, 9 Tn2008 10,11 and Tn2009. 12 The epidemiology of the acquired CHDLs has frequently been assessed together with the clonal epidemiology by MLST, a sequence-based bacterial typing method developed at Oxford 13 and at the Institut Pasteur 14 that is often used to compare lineage differences in a species worldwide. 15 The bla OXA-23 gene has frequently been found in strains of the largest global clone 2 (GC2), which corresponds to clonal complex (CC) 92 in the Oxford scheme and CC2 in the Pasteur scheme, while the gene has occasionally been found in strains that belong to GC1 (Oxford CC109 and Pasteur CC1), but not in the GC3 (Oxford CC187 and Pasteur CC3). 8 The carbapenem resistance rate in A. baumannii is extremely high in South Korea and mostly due to the bla OXA-23 gene. To better understand the implications of this health challenge, we undertook a WGS analysis of the representative Acinetobacter spp. clinical isolates that possess prevalent transposons carrying the gene, to assess the nationwide dissemination of this human pathogen carrying bla OXA-23 .
Materials and methods

Bacterial strains
Thirty general hospitals geographically distributed throughout South Korea were each asked to collect up to 18 non-replicate isolates of Acinetobacter from clinical specimens between October and December 2013 ( Figure S1 , available as Supplementary data at JAC Online). A total of 406 nonduplicated Acinetobacter clinical strains were collected and species identification was confirmed by rpoB gene sequences.
Antimicrobial susceptibility testing
Disc diffusion testing was conducted using antimicrobial discs (Becton Dickinson, Sparks, MD, USA) on cationic-adjusted Mueller-Hinton (MH) agar (Difco Laboratories, Detroit, MI, USA) according to CLSI guidelines. 16 MICs of imipenem and meropenem were determined with the agar dilution method using MH agar following CLSI guidelines. 17 Both A. baumannii ATCC 19606 and Acinetobacter genomospecies 14TU ATCC 17905, which have been used as quality-control strains for susceptibility testing of Acinetobacter spp. strains, were used in addition to accumulated in-house data. 18 
MLST
MLST was performed according to the Oxford scheme (http://pubmlst.org) 13 as previously described. Briefly, fragments of seven housekeeping genes (gltA, gyrB, gdhB, recA, cpn60, gpi and rpoD) were amplified by PCR, and the amplicons were sequenced to define the type number of each allele. The eBURST algorithm 19 was used to assign sequence types (STs) to CCs.
Carbapenem resistance determinant and bla OXA-23 -associated transposon identification
Carbapenem-resistant isolates were screened by PCR for known acquired carbapenemases, such as bla OXA-23 , bla OXA-24/-40 , bla OXA-58 , bla OXA-48 , bla OXA-182 , bla IMP , bla VIM , bla KPC , bla SPM and bla NDM , together with insertion sequence ISAba1 upstream from the intrinsic bla OXA-51-like . 20 PCR mapping was carried out by a two-step strategy ( Figure S2 ) using the primers listed in Table S1 for the strains that harboured bla OXA-23 and the associated transposons Tn2006, 21 Tn2007, 21 Tn2008 9 and Tn2009. 9 First, three independent reactions were performed to determine the presence of ISAba1 upstream from the bla OXA-23 gene and expansion downstream from the gene. A second set of reactions was performed to confirm the transposon type. Particularly for Tn2006, interruption of the sup gene for sulphate permease was verified in the secondary reaction, allowing us to evaluate its integration in the resistance island AbaR4.
WGS
For bacterial WGS, single-molecule real-time sequencing was carried out on a PacBio RSII instrument (Pacific Biosciences, Menlo Park, CA, USA) as previously described using genomic DNA from the Acinetobacter spp. strains extracted by a Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA).
GenBank accession numbers
The genomes of 14 Acinetobacter strains have been deposited in GenBank under accession numbers CP020573-CP020575 for 15A5, CP020576-CP020578 for SSA12, CP020579 for SAA14, CP020580-CP020581 for SSMA17, CP020582-CP020584 for JBA13, CP020585-CP020586 for CBA7, CP020587-CP020588 for SSA3, CP020589-CP020590 for 15A34, CP020591 for SSA6, CP020592-CP020593 for USA2, CP020594-CP020595 for USA15, CP020596-CP020597 for HWBA8, CP020598 for WKA02, and NBNJ00000000 for SSMA8 under the BioProject PRJNA380857.
Results
An alarmingly high rate of carbapenem resistance in A. baumannii with a clonal epidemiology A total of 406 non-duplicated Acinetobacter spp. clinical strains were collected, consisting of 356 A. baumannii, 26 Acinetobacter nosocomialis, 21 Acinetobacter pittii and one each of Acinetobacter bereginiae, Acinetobacter haemolyticus and Acinetobacter gyllenbergii.
Based on the Oxford scheme of MLST, a total of 55 different STs, including 34 previously unregistered, were found in A. baumannii isolates. The STs comprised five CCs, i.e. CC92 (82%, n " 291), CC20 (5%, n " 18), CC110 (2%, n " 7), CC397 (0.8%, n " 3) and CC114 (0.6%, n " 2), along with 34 singletons (Table S2 ). The predominant CC92 strains were spread throughout the Korean peninsula and others were identified sporadically with obvious clonal outbreaks in certain hospitals, i.e. ST1225 in Gangwon province ( Figure S1 ). In parallel, non-baumannii Acinetobacter spp. (NBA) strains were frequently isolated through intra-hospital outbreaks that occurred in Seoul (site #2), in Busan (site #3) and in Daejeon.
A total of 314 (88%) A. baumannii strains were resistant to carbapenems (Table 1 ) and all except two were MDR strains (Table S3 ). The MIC 50 and MIC 90 of both imipenem and meropenem were 16 and 32 mg/L, respectively. Carbapenem MICs in NBA clinical strains are presented in Table S4 . Seven of 50 (14%) strains, five A. nosocomialis and two A. pittii, were resistant to both carbapenems, and all but two A. nosocomialis were MDR. The MIC 50 and MIC 90 of imipenem were 0.5 and 16 mg/L, respectively, and those of meropenem were 0.125 and 8 mg/L, respectively.
The bla OXA-23 gene was identified in 98% (309/314) of the carbapenem-resistant A. baumannii strains, and ISAba1 was detected upstream from bla OXA-51-like in the eight bla OXA-23 -possessing strains. Five strains did not have the bla OXA-23 gene, but had ISAba1-bla OXA-51-like . The strains that harboured only the bla OXA-23 gene mostly belonged to CC92. The five strains that possessed only ISAba1-bla OXA-51-like belonged to either CC92 or CC110.
Transposons carrying bla OXA-23 were investigated by PCR mapping ( Figure S2 ). Tn2009 was identified in 167 (54%), Tn2006 in 137 (44.3%) and Tn2008 in 5 (1.6%) of 309 bla OXA-23 -positive carbapenem-resistant A. baumannii strains. None possessed Tn2007. Of note, the detected Tn2006s were all bracketed by the sup gene for sulphate permease, presumably in the A. baumannii resistance island AbaR4. Tn2009 was identified only in CC92, particularly in ST191, with one exception in ST1273. Tn2008 was also detected only in ST208 of CC92 while Tn2006 was found in strains in CC92, CC20, CC110 and CC397, and in singletons ST373, ST1257 and ST1262.
Among the seven carbapenem-resistant NBA strains, the bla OXA-23 gene was identified in four A. nosocomialis and in one
The bla OXA-23 transposons of Acinetobacter JAC A. pittii, which were all carried by Tn2006, and the remaining two strains, one A. nosocomialis and one A. pittii, contained bla OXA-58 (Table S4) .
Strain panels for further genomic studies
A total of 14 strains were selected for further genomic studies: 12 representatives from the surveillance including 6 A. baumannii and 1 A. nosocomialis strains that had Tn2006, 2 A. baumannii having Tn2008 and 4 carrying Tn2009, along with 2 comparative pandrug-resistant A. baumannii strains, which were isolated either 8 months before or after the surveillance period: Tn2009-possessing 15A5 isolated in January 2013, and Tn2006-possessing 15A34 isolated in August 2014 (Table S5) .
The six Tn2006-possessing A. baumannii strains belonged to diverse STs, i.e. both USA2 and SSA6 strains belonged to ST357 of CC92, WKA02 to ST447 of CC20, HWBA8 to ST229 of CC110, USA15 to ST491 of CC397, and 15A34 to ST872 of CC92, while the Tn2008-and Tn2009-possessing strains were all attached to CC92, i.e. Tn2008-possessing CBA7 and SSMA8 belonged to ST208 of CC92, and Tn2009-possessing JBA13, SSMA17, SAA14, SSA12 and 15A5 belonged to ST191 of CC92. All the Tn2008 had an ISAba1 copy 27 bp upstream from the bla OXA-23 gene, indicating Tn2008 rather than Tn2008B. The 13 A. baumannii strains, as well as 1 A. nosocomialis strain presented MDR phenotypes and carbapenem MICs varied from 8 to 64 mg/L.
Genomic background of the bla OXA-23 -transposoncarrying bacterial host
The genome of A. baumannii strains was composed of a single chromosome from 3.87 to 4.08 Mb in size and that of A. nosocomialis was 4.13 Mb (Table S5 ). The genome of SSMA8 was composed of two contigs for chromosome-carrying genes for large or small ribosomal subunits. All 13 A. baumannii strains possessed prophages derived from B/-B1251, a bacteriophage capable of lysing carbapenem-resistant A. baumannii strains. 22 The A. nosocomialis SSA3 did not have any prophage-like element.
Ten A. baumannii and one A. nosocomialis strains possessed one or two plasmids, which were mostly cryptic with the exception of three, namely pSSA3, pUSA15 and pHWBA8, in sizes that ranged from 8.7 to 195.8 kb (Figure 1 , Table S5 ).
Acquired antimicrobial resistance genes
In each chromosome 2-10 genes, acquired for antimicrobial resistance, were identified (Table S5) ; these genes were all gathered in resistance islands except the bla OXA-23 gene located in the vehicles Tn2008 and Tn2009. The sul1, sul2, tetA, bla PER-1 and strAB genes, along with bla OXA-23 within Tn2006, were often carried either by AbaR or by AbGRI1 and the aacA4, catA8 and aadA genes, as gene cassettes of class 1 integron, and armA, msrE, mphE and bla TEM-1 were frequently carried by AbGRI2.
Resistance genes were also located in three non-cryptic plasmids: tet(39) in the 11.4 kb pSSA3, aphA6 and bla OXA-23 in the 98.3 kb pUSA15, and aac(3)-IIa, armA, bla PER-7 , msrE, mphE, sul1, sul2, cmlA1, arr-2 and tet(B) in the 195.8 kb pHWBA8.
Resistance islands in the chromosome
Either an AbaR or an AbGRI1 was integrated at the comM gene for ATPase (Figure 2 ), generating 5 bp target site direct repeats (DRs): GCGGT in A. baumannii and GCGGC in A. nosocomialis. The five ST191 strains of GC2 possessed the 9148 bp Tn6022, a backbone of the AbGRI1. Non-ST191 GC2 strains carried the AbGRI1 in sizes from 36 to 51 kb or a 54 kb AbaR: a 36 kb AbGRI1 in CBA7 and SSMA8; a 51 kb AbGRI1 in SSA6 and 15A34 carrying Tn2006; and a 54 kb AbaR25-like in USA2 harbouring Tn2006. Non-GC2 strains possessed AbaRs: a 31 kb AbaR10 in USA2 belonging to GC1 carried heavy-metal resistance arsHBRC and cadRA genes, and an intact form of a 17 kb AbaR4 in HWBA8 and WKA02 of singleton STs along with A. nosocomialis SSA3 had Tn2006. Of note, A. nosocomialis SSA3 possessed an identical extra copy of AbaR4 in the opposite semicircle of the chromosome, which is not associated with the comM gene.
The AbGRI2 was separated into two pieces, AbGRI2-0a-and AbGRI2-0b-like, probably by a chromosomal recombination. 23 The AbGRI2-0a-like was located adjacent to the gene encoding arginine N-succinyltransferase in the chromosomes of three GC2 strains, SSA6 of ST357, 15A34 of ST872, and 15A5 of ST191 (Figures 1 and 2) . The other piece, AbGRI2-0b-like, which was Yoon et al. located between two genes encoding a major facilitator superfamily transporter and a putative GCN5-related N-acetyltransferase, was identified in five more GC2 strains: SAA14, SSMA17, SSA12 and JBA13 of ST191, and USA2 of ST357. The AbGRI2-0b-like carried one class 1 integron harbouring three gene cassettes, and a copy of composite Tn6020, IS26-aphA1-IS26, was located upstream from the class 1 integron in the chromosome of SSA6. The AbGRI2-0b, with the exception of that in SAA14, contained the repAciN gene for a plasmid replicase specific to Acinetobacter spp. 24 and the structure was nearly identical to the pMDR-ZJ06 plasmid of MDR A. baumannii strain MDR-ZJ06, 12 which supports the notion of rapid acquisition of multiple foreign antimicrobial determinants by active exchange of gene clusters between a plasmid and a chromosome.
Multiplication of the bla OXA-23 -associated transposons
The 14 strains possessed 1-3 copies of bla OXA-23 -associated transposons flanked by DRs ( Figure S3 ) in the chromosome and, exceptionally, the USA15 carried one copy of Tn2006 in the chromosome and another copy in a plasmid. Multiple copies of the transposons in each strain had identical base changes ( Figure S4 ), which indicates that the transposon multiplication was an intracellular event that had occurred via a replicative transposition. In a broader perspective, the base changes were shared by the strains from the surveillance, except those in strain USA15, whereas the comparator strains 15A5 and 15A34 possessed transposons readily distinguishable by nucleotide base differences.
The Tn2006 primarily targeted the sup gene in AbaR4, evidenced by at least one transposon bracketed by AbaR4 in every Tn2006-possessing strain (Figure 1) . In A. baumannii strains belonging to GC2, the AbaR4 was duplicated along with Tn2006. The atypical GC1 A. baumannii USA15, possessing a copy of Tn2006 bracketed by AbaR4 in a plasmid, had reintegrated Tn2006 from the plasmid into the chromosome via the transposon itself. In A. nosocomialis SSA3, the Tn2006 was flanked by AbaR4 and was multiplied either with or without AbaR4. The bla OXA-23 transposons of Acinetobacter
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Tn2008 has a single ISAba1 copy upstream from bla OXA-23 ; however, a 16 bp imperfect inverted repeat sequence in the 5 0 -end of the transposon resulted in a functional transposable element that is always bracketed by DRs. 25 Nucleotide differences in the transposon indicated that it was a pandemic Tn2008 rather than the transposon Tn2008B endemic in China emerging in 2016. 25 One of the three Tn2008 integration sites in SSMA8 was identical to that in CBA7, suggesting that the CBA7 clone was first disseminated and subsequent intracellular multiplication of the transposon occurred.
Similarly, the fundamental site of the Tn2009 integration was identical in every strain, revealing that duplication of the transposon came after the dissemination of the single-Tn2009-possessing clone belonging to ST191. It should be noted that the nucleotide sequence of Tn2009 was identical in all strains except that in the comparative strain 15A5.
Multiple bla OXA-23 transposons associated with elevated carbapenem MICs
The three transposons had identical -35 and -10 sequences of the promoter region for bla OXA-23 which promote the same level of gene expression. Indeed, quantitative RT-PCR for the strains possessing a single copy of any transposon resulted in similar levels of transcription. This indicates that the different carbapenem MICs could be due to the gene copy number rather than the differing levels of gene expression.
For the 16 Tn2006-, 5 Tn2008-and 10 Tn2009-possessing strains from the surveillance that displayed various carbapenem MICs, the number of bla OXA-23 gene copies was determined by quantitative PCR, with the rpoB and secE genes serving as internal controls. There were 1-6 Tn2006 copies, which were located either in the chromosome or in a plasmid, 1-3 Tn2008 copies, and 1 or 2 Tn2009 copies. Based on the parametric method, using Pearson's correlation, 26 linear relationships between the number of transposon copies and imipenem MICs were found (Figure 3) . The group that possessed Tn2008 displayed a very strong linear relationship [correlation coefficients (r) " 0.979], that is statistically significant (P " 0.004), while the group with either Tn2006 or Tn2009 presented non-significant moderate correlations whose r values were 0.488 (P " 0.055) and 0.430 (P " 0.214), respectively.
Amplification of each transposon was demonstrated on MH agar plates supplemented with serial 2-fold dilutions containing imipenem ranging from 16 to 128 mg/L by inoculating the strain that had a single copy of any transposon in the chromosome: HWBA8 and WKA02 for Tn2006, CBA7 for Tn2008, and SSMA17 for Tn2009. Interestingly, Tn2008-carrying CBA7 and Tn2009-possessing SSMA17 strains showed immediate increases of imipenem MIC, exhibiting growth on the agar plate with 128 mg/L imipenem, while growth of Tn2006-harbouring HWBA8 and WKA02 were both inhibited on the plate with 32 mg/L imipenem. This result implied that the multiplication of Tn2006, which presented strong target specificity, was not as efficient as the other 28 and between 2011 and 2012. 29 In 2013, as we have shown in this study, the rate of carbapenem resistance mostly associated with bla OXA-23 rose alarmingly to 88% in A. baumannii belonging to a wide range of STs. In parallel, the NBA strains had carbapenem resistance rates of 13.7%, mainly caused either by bla or bla OXA-58 in 2013, which was increased from 8% by metallo-blactamase bla IMP and bla VIM genes in 2008. 18 This nationwide surveillance study indicated that acquisition of the bla OXA-23 gene was largely associated with two bla OXA-23 -associated transposons, Tn2006 and Tn2009. Tn2006, which has sufficient intercellular transfer efficiency, was transferred to various strains, including NBA, via a plasmid or by the transposon by itself. In contrast, spread of Tn2008 and Tn2009 was entirely dependent on clonal dissemination of the bacterial host. Tn2009 was carried by predominant A. baumannii ST191 of GC2, allowing nationwide dissemination, whereas Tn2008 was not prevalent because of the rarity of host ST208. Similarly, Tn2008 carried by A. baumannii of CC92 in China 30 and Tn2006 and Tn2008 carried by CC92 in Australia 31 have been found to be responsible for domestic dissemination of carbapenem-resistant A. baumannii.
ISAba1 is duplicated during the insertion at a new target site, indicating a copy-and-paste mechanism of transposition. Tn2006, which is a composite transposon of bla OXA-23 bracketed by two copies of ISAba1, is similarly transposed, presenting lower transposition efficiency than the insertion sequence itself. 32 The transposition mechanism of the other two, Tn2008 with a single ISAba1 copy upstream from the bla OXA-23 gene and Tn2009 bracketed by two copies of ISAba1 in the opposite direction, is still unknown. Evidenced by having duplicated copies of the transposon while maintaining the primary site, the same copy-and-paste mechanism was suggested for both transposons. The differing transposition efficiency of these transposons requires further study. Gene amplification resulting in higher-level resistance has developed in response to antimicrobials as an adaptive mechanism by bacteria. 27 In general, more bla OXA-23 copies corresponded to elevated imipenem MICs, and the Tn2008-possessing strains in particular presented a clear correspondence. The upwards linear relationship in the Tn2006-and Tn2009-possessing strains is clearly unexpected, but is probably due to the unstable Tn2006 copy number by the plasmid location and the limited copy numbers of Tn2009, resulting in doubled imipenem MICs. Recently, Hua et al. 33 have demonstrated that the bla OXA-23 gene frequently multiplied in clinical A. baumannii isolates. By comparing the number of gene copies and imipenem susceptibility, r 2 values ,0.8 were considered statistically insignificant. However, this interpretation is possibly incorrect since the P value is the basis for statistical significance and the r value, not the r 2 , indicates linearity of the correlation. 26 
Conclusions
In this study, the increased prevalence of the bla OXA-23 gene was scrutinized in terms of epidemiology and a snapshot of genome dynamics associated with three mobile genetic elements and the bacterial host. Our findings indicate that: (i) clonal spread of A. baumannii ST191 carrying Tn2009 and (ii) intra-and interspecies horizontal dissemination of Tn2006 are responsible for the wide spread of carbapenem resistance in Acinetobacter spp.; and finally, (iii) multiplied bla OXA-23 -associated transposons give rise to high-level carbapenem resistance in these bacterial hosts. Figure 3 . Correlation between imipenem MICs and copy number for Tn2006 (a), Tn2008 (b) and Tn2009 (c). The correlation coefficient (r) was calculated by the parametric method using SPSS Statistics (version 23, IBM Corp.) and the significance (P) was determined by a two-tailed method using the correlation value and the sample size.
The bla OXA-23 transposons of Acinetobacter 
Transparency declarations
None to declare.
Supplementary data
Figures S1-S4 and Tables S1-S5 appear as Supplementary data at JAC Online.
